Sort   by:  
 Page size 
UnknownA phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma.
Not available
S-EPMC7006234 | biostudies-literature
UnknownPhase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma.
Not available
S-EPMC4492237 | biostudies-literature
UnknownImpaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells.
Not available
S-EPMC2867326 | biostudies-literature
UnknownMesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes.
Not available
S-EPMC5354724 | biostudies-literature
UnknownContinued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
Not available
S-EPMC5976545 | biostudies-literature
UnknownMicrotubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins.
Not available
S-EPMC4321245 | biostudies-literature
Sort   by:  
 Page size